Time to Take the Lead – Practical Utilization of SGLT2 Inhibitors

Published: 07 September 2020

  • Views:

    Views Icon 332
  • Likes:

    Heart Icon 7

Overview

Full programme

  • Views:

    Views Icon 332
  • Likes:

    Heart Icon 7
Part 2

of 5

SGLT2i are Cardiovascular Drugs

Overview

This educational symposium first broadcast at the ESC Congress 2020 discusses how SGLT2 inhibitors should be utilised by cardiologists in everyday practice

This independent medical education symposium was supported by a grant from the Boehringer Ingelheim & Eli Lilly and Company alliance.

Learning objectives

  • Understand current guidelines and utilisation of SGLT2i
  • Describe the potential mechanism of benefit of SGLT2i
  • Initiate and manage SGLT2i in appropriate patients

More from this programme

Faculty biographies